Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
2.990
+0.040 (1.36%)
Dec 20, 2024, 4:00 PM EST - Market closed
Eupraxia Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 107 | 111 | 58 | 28 | - | - | |
| Market Cap Growth | -32.69% | 90.50% | 111.19% | - | - | - | |
| Enterprise Value | 98 | 96 | 43 | 8 | - | - | |
| Last Close Price | 2.99 | 4.16 | 2.69 | 2.30 | - | - | |
| Debt / Equity Ratio | 0.01 | 11.71 | 1.25 | 0.52 | -0.59 | -0.66 | |
| Quick Ratio | 3.70 | 1.01 | 6.00 | 13.37 | 0.03 | 0.12 | |
| Current Ratio | 4.17 | 1.02 | 6.08 | 13.49 | 0.05 | 0.13 | |
| Return on Equity (ROE) | -301.58% | -715.19% | -178.04% | - | - | - | |
| Return on Assets (ROA) | -110.11% | -88.37% | -52.20% | -68.51% | -59.25% | -124.28% | |
| Return on Capital (ROIC) | -128.67% | -126.40% | -58.41% | -110.75% | - | - | |
| Buyback Yield / Dilution | -40.29% | -25.21% | -55.45% | -102.75% | -0.01% | -0.00% | |
| Total Shareholder Return | -40.29% | -25.21% | -55.45% | -102.75% | -0.01% | -0.00% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.